Welcome to our dedicated page for Cencora SEC filings (Ticker: COR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Cencora moves billions of dollars in branded, generic, and specialty drugs—and how much it sets aside for opioid litigation—means combing through dense regulatory documents. Cencora SEC filings explained simply is what most investors search for when a new disclosure lands. Stock Titan solves that problem by turning every freshly posted exhibit, footnote, and schedule into plain-English insights within minutes.
Our platform reads each Cencora annual report 10-K simplified, compares segment margins, and highlights cash-flow drivers hidden in accounting tables. You’ll also receive instant alerts the moment a director files Cencora Form 4 insider transactions real-time. Key features include:
- AI-powered summaries that clarify complex wording and accounting changes
- Real-time push notifications for new 10-K, 10-Q, 8-K, and Cencora insider trading Form 4 transactions
- Side-by-side visuals that streamline Cencora earnings report filing analysis
Whether you’re waiting for the next Cencora quarterly earnings report 10-Q filing, researching Cencora executive stock transactions Form 4, or need Cencora 8-K material events explained after an unexpected acquisition, everything is organized in one place. We even map the pages inside the Cencora proxy statement executive compensation section, so pay packages are only a click away. Stop downloading PDFs; start understanding Cencora SEC documents with AI that surfaces the metrics that matter.
Cencora (COR) reported insider equity activity by President & CEO and Director Robert P. Mauch. On 11/13/2025, he acquired 42,944 common shares at $0 upon satisfaction of performance share unit criteria, then had 18,677 shares withheld at $312.53 to cover taxes, resulting in 67,079 shares directly owned after these transactions. Separately, on 11/12/2025, he received a grant of 15,960 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora (COR) reported insider activity by CFO James F. Cleary. On 11/13/2025, he acquired 30,062 shares of common stock at $0 upon satisfaction of performance share unit criteria, and 13,901 shares were withheld at $312.53 to satisfy tax obligations tied to that vesting. Following these transactions, he directly held 133,889.3479 shares.
Separately, on 11/12/2025, Cleary was granted 4,733 restricted stock units for no consideration. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora (COR) reported an insider equity award. EVP, Chief Data & Info Officer Pawan Verma filed a Form 4 for a grant of 3,963 restricted stock units (RSUs) on 11/12/2025.
The RSUs were received for no consideration and vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Each RSU corresponds to one share of Cencora common stock, and the filing lists 3,963 derivative securities beneficially owned Direct (D) following the transaction.
Cencora (COR) Executive Vice President Elizabeth S. Campbell filed a Form 4 disclosing equity changes. On 11/13/2025, she acquired 20,613 shares of common stock at $0 upon performance share unit vesting, and a same‑day withholding transaction covered taxes for 9,532 shares at $312.53.
Separately, on 11/12/2025 she received a grant of 3,523 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Following these transactions, she beneficially owned 26,388.141 shares, held directly.
Cencora, Inc. (COR)
In a separate equity grant, on 11/12/2025 the officer received 2,271 Restricted Stock Units at $0. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora, Inc. (COR) reported insider equity changes for Executive Vice President Silvana Battaglia. On 11/13/2025, she acquired 12,885 shares of common stock at $0 upon the satisfaction of performance criteria tied to prior performance share units, and disposed of 5,612 shares at $312.53 to satisfy tax withholding related to that vesting. Following these transactions, she beneficially owns 19,947.464 common shares, held directly.
Separately, on 11/12/2025, she received a grant of 2,202 Restricted Stock Units at $0, which vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora, Inc. (COR) reported insider activity by Executive Vice President Silvana Battaglia on 11/07/2025. Two restricted stock unit (RSU) tranches vested and were settled into common stock (codes M) for 1,265 shares and 1,084 shares. To cover tax withholding, she had broker-assisted sales (code F) of 551 shares and 473 shares at $360.70 per share. After these transactions, she directly owned 12,674.464 common shares.
The footnotes state the first RSU grant vested in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025, and the second RSU grant vests on 11/08/2024, 11/08/2025, and 11/08/2026. The 2023 grant is fully settled; 1,085 RSUs from the 2024 grant remain outstanding.
Cencora (COR) reported insider activity by an Executive Vice President. On 11/07/2025, two restricted stock unit tranches converted to common stock: 2,023 shares and 1,830 shares (coded “M”). To cover taxes, the filer disposed of 798 shares and 572 shares at $360.7 per share (coded “F”). Following these transactions, directly beneficially owned common stock stood at 15,307.141 shares. The vesting schedules referenced cover installments on 11/09/2023–2025 and 11/08/2024–2026.
Cencora (COR) reported a Form 4 for CFO James F. Cleary reflecting RSU vesting and tax withholding on 11/07/2025. Two RSU tranches converted to common stock: 2,951 shares and 2,439 shares (codes M). To satisfy withholding taxes, the company withheld and disposed of 1,250 shares and 705 shares at $360.7 per share (code F). Following these transactions, Cleary’s directly held common stock totaled 117,728.3479 shares.
The vested RSUs relate to grants scheduled to vest in equal annual installments on 11/9/2023–11/9/2025 and 11/08/2024–11/08/2026, as noted in the filing.
Cencora (COR) reported insider activity by its SVP & Chief Accounting Officer. On 11/07/2025, two restricted stock unit (RSU) tranches vested and were settled into common stock: 1,433 shares and 1,398 shares (both at $0 exercise price).
To cover withholding taxes tied to the vesting, the insider disposed of 411 shares and 366 shares at $360.7 per share. Following these transactions, the insider directly holds 19,208 shares of common stock. The RSUs relate to grants vesting in equal annual installments on 11/09/2023–11/09/2025 and 11/08/2024–11/08/2026.
FAQ
What is the current stock price of Cencora (COR)?
What is the market cap of Cencora (COR)?
